Cedars Sinai Intellectual Property Co - 08 Mar 2023 Form 4 Insider Report for Prometheus Biosciences, Inc.

Role
10%+ Owner
Signature
/s/ Timothy K. Andrews, attorney-in-fact
Issuer symbol
N/A
Transactions as of
08 Mar 2023
Net transactions value
-$99,120,350
Form type
4
Filing time
08 Mar 2023, 20:30:17 UTC
Previous filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXDX Common Stock Sale $99,120,350 -865,000 -18% $114.59 4,001,132 08 Mar 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Cedars Sinai Intellectual Property Co is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The securities reported herein are held of record by Cedars Sinai Intellectual Property Company, which is a wholly owned subsidiary of Cedars-Sinai Medical Center.